Yohimbine

Table of contents

  • Brand Names
  • Chemistry
  • Pharmacologic Category
  • Mechanism of Action
  • Unlabeled Use
  • Pregnancy and Lactation Implications
  • Contraindications
  • Warnings and Precautions
  • Adverse Reactions
  • Caution and personalized dose adjustment in patients with the following genotypes
  • Other genes that may be involved
  • Substrate of
  • Inhibits
  • Induces
  • Drug Interactions
  • Dosage
  • Pharmacokinetics and Pharmacodynamics
  • Special Considerations

Brand Names

Europe

Austria: Yocon; Belgium: Yocoral; Denmark: Virigen; France: Yocoral, Yohimbine; Germany: Pluriviron, Yocon, Yohimbin Spiegel; Hungary: Yohimbin Spiegel; Luxembourg: Yocoral, Yohimbine Houde.

North America

Canada: Yocon, Yohimbine; USA: Aphrodyne, Yocon.

Latin America

Brazil: Coryananthe yohimbe.

Drug combinations

Chemistry

Yohimbine Hydrochloride: C~21~H~26~N~2~O~3~ HCl. Mw: 390.90. 17α-Hydroxy-20-α-yohimban-16-β-carboxylic acid, methyl ester, hydrochloride. CAS-65-19-0.

Pharmacologic Category

Other Miscellaneous Therapeutic Agents. (ATC-Code: G04BE04).

Mechanism of action

Indole alkaloid derived from bark of yohimbe tree (Corynanthe yohimbe). Produces presynaptic α~2~-adrenergic blockade. Peripheral autonomic effect is to increase cholinergic and decrease adrenergic activity. Also exerts stimulating effect on mood and mild antidiuretic effect.

Therapeutic use

Pregnancy and lactiation implications

Generally not for use in females. Do not use in pregnancy.

Unlabeled use

Treatment of SSRI-induced sexual dysfunction. Weight loss. Impotence. Sympathicolytic and mydriatic. May have aphrodisiac activity.

Contraindications

Hypersensitivity to yohimbine or any component of the formulation. Renal disease.

Warnings and precautions

Can cause nausea or vomiting. Use with caution in cardiovascular disease (may cause high blood pressure and tachycardia). Should not be used in history of gastric or duodenal ulcer, or in psychiatric disorders (may cause anxiety). Do not use in the elderly. Generally not for use in females. Do not use in children, or in pregnancy. May cause neutropenia.

Information

Legal

Legal Notice
Privacy Policy
Cookie Policy

Contact

Phone: +34-981-780505
Email: genomicmedicine@wagem.org
Location: Sta Marta de, C. P. Babío, S/N, 15165 Bergondo, A Coruña

Copyright © 2023 WAGEM

Add to cart